Fair Game: Valeant’s High-Price Drug Strategy
Saturday, October 3, 2015 - 08:30
in Mathematics & Economics
Valeant, which has grown by acquiring rivals and slashing their staffs, has drawn the ire of a House panel, which is now considering a subpoena on the company’s price increases.